Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review

Javaid Iqbal, Ophira M. Ginsburg, Thiwanka D. Wijeratne, Anthony Howell, Gareth Evans, Ivana Sestak, Steven A. Narod

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background: Breast cancer prevention with tamoxifen in high-risk women is limited due to concerns of endometrial cancer and thromboembolism. We report the risk of endometrial cancer, deep vein thrombosis and pulmonary embolism in women
    Original languageEnglish
    Pages (from-to)318-328
    Number of pages10
    JournalCancer Treatment Reviews
    Volume38
    Issue number4
    DOIs
    Publication statusPublished - Jun 2012

    Keywords

    • Breast cancer
    • Chemoprevention
    • Deep vein thrombosis
    • Endometrial cancer
    • Pulmonary embolism
    • Tamoxifen
    • Young women

    Fingerprint

    Dive into the research topics of 'Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review'. Together they form a unique fingerprint.

    Cite this